{"id":46369,"date":"2022-07-20T14:01:42","date_gmt":"2022-07-20T12:01:42","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\/"},"modified":"2022-07-20T14:01:42","modified_gmt":"2022-07-20T12:01:42","slug":"medical-microinstruments-secures-75m-to-advance-robotic-microsurgery","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\/","title":{"rendered":"Medical Microinstruments Secures $75M to Advance Robotic Microsurgery"},"content":{"rendered":"
\n

\nSeries B financing will accelerate clinical trials and global commercialization of the company\u2019s Symani\u00ae<\/sup> Surgical System<\/i>\n<\/p>\n

PISA, Italy–(BUSINESS WIRE)–Medical Microinstruments, Inc. (MMI)<\/a>, a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced it has raised $75 million in Series B financing. Deerfield Management led the round with participation from new investors, RA Capital Management and Biostar Capital, as well as existing investors, Andera Partners, Fountain Healthcare Partners, Panak\u00e8s Partners and Sambatech. The company also announced the addition of three new members to its board of directors.\n<\/p>\n

<\/a><\/p>\n

\nIn addition, the company announced its corporate redomicile from Italy to the United States. The recently opened Center of Excellence<\/a> facility in Pisa, Italy, with 96 employees will continue to be the hub of the company\u2019s research and development, manufacturing, and other business activities.\n<\/p>\n

\nProceeds from this financing round and the company\u2019s planned U.S. presence will launch MMI into its next stage of growth as it continues its mission to improve the quality of patient care by pushing the boundaries of microsurgery. The company seeks to expand indications and support ongoing commercialization efforts for the Symani\u00ae<\/sup> Surgical System in Europe where it received CE mark in 2019. MMI also intends to accelerate plans to commercialize in the U.S. and Asia-Pacific, as well as advance clinical research including securing an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration to conduct a pivotal study. The Symani System was developed specifically to address the challenges of microsurgery and is the only system that offers NanoWrist\u00ae<\/sup> Instruments designed to improve a surgeon\u2019s ability to access and suture small, delicate anatomy.\n<\/p>\n

\n\u201cThis financing round, coupled with our commitment to access the U.S. market and the addition of visionary leaders to our board, is an exciting moment for the surgical robotics space,\u201d said Mark Toland, CEO of MMI. \u201cWe\u2019re pleased to have bridged the Atlantic with premier U.S. life science investors, and existing European investors, who share our same vision of bringing microsurgical robotics to the world.\u201d\n<\/p>\n

\nThe company\u2019s new board members are Andrew ElBardissi, MD, Tess Cameron and Arturo Baroncelli. Dr. ElBardissi is a partner at Deerfield Management, with extensive experience serving as a board member for innovative healthcare companies. Ms. Cameron serves as principal for RA Capital Management and currently sits on the boards of Avilar Therapeutics and Nodexus Inc. Baroncelli previously worked as a robotics business development manager for Comau and will represent MMI\u2019s founders on the board.\n<\/p>\n

\n\u201cWe are thrilled to add further depth and experience to the MMI Board and look forward to working with our new board members to build the robotic microsurgical space,\u201d said Andrew Cleeland, Chairman of the Board for MMI.\n<\/p>\n

\n\u201cThe MMI technology is one of the most significant transformational advancements in surgical robotics that we have seen,\u201d said Dr. ElBardissi. \u201cHaving the world\u2019s smallest wristed instruments opens up the field of \u2018micro\u2019 robotics to a completely new level of treatment spanning microsurgery for cancer, trauma, orthopedic, pediatric, and one day, neurosurgery patients. Symani will be the future of how microsurgery is performed worldwide.\u201d\n<\/p>\n

\n\u201cRobotic microsurgery has enormous potential to both improve the standard of care for patients and help surgeons manage procedures that require delicate precision,\u201d said Ms. Cameron. \u201cI look forward to supporting MMI and its world-class team as it begins this exciting chapter.\u201d\n<\/p>\n

\nThe Symani Surgical System is designed to improve a surgeon\u2019s ability to repair anatomical structures such as veins, arteries, nerves and lymphatic vessels as small as 0.3 mm in diameter. The platform provides motion scaling and tremor reduction to allow precise micro-movements. Its NanoWrist technology is the world\u2019s smallest wristed instrumentation and is intended to improve a surgeon\u2019s natural dexterity and range of motion beyond the capability of the human hand.\n<\/p>\n

\nAbout Medical Microinstruments, Inc.<\/b>\n<\/p>\n

\nMedical Microinstruments, Inc. (MMI) was founded in 2015 near Pisa, Italy to enhance surgical performance through the development of a robotic system that enables surgeons to achieve better outcomes in microsurgery. The Symani Surgical System combines proprietary innovations including the world\u2019s smallest wristed microinstruments as well as tremor-reducing and motion-scaling technologies. Together, these powerful capabilities allow more surgeons to successfully perform microsurgery while expanding the field of supermicrosurgery. MMI is backed by international medtech investors including Andera Partners, BioStar, Deerfield Management, Fountain Healthcare Partners, Panak\u00e8s Partners, RA Capital and Sambatech.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:
\n
Sarah Lundberg
\n
Health+Commerce
\n
sarahlundberg@healthandcommerce.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Series B financing will accelerate clinical trials and global commercialization of the company\u2019s Symani\u00ae Surgical System PISA, Italy–(BUSINESS WIRE)–Medical Microinstruments, Inc. (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced it has raised $75 million in Series B financing. Deerfield Management led the round with participation from new investors, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46369","6":"format-standard","7":"category-industry"},"yoast_head":"\nMedical Microinstruments Secures $75M to Advance Robotic Microsurgery - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medical Microinstruments Secures $75M to Advance Robotic Microsurgery - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Series B financing will accelerate clinical trials and global commercialization of the company\u2019s Symani\u00ae Surgical System PISA, Italy–(BUSINESS WIRE)–Medical Microinstruments, Inc. (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced it has raised $75 million in Series B financing. Deerfield Management led the round with participation from new investors, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-20T12:01:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220720005238\/en\/1518642\/21\/MMI-GREY-CMYK_CL.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Medical Microinstruments Secures $75M to Advance Robotic Microsurgery\",\"datePublished\":\"2022-07-20T12:01:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\\\/\"},\"wordCount\":751,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220720005238\\\/en\\\/1518642\\\/21\\\/MMI-GREY-CMYK_CL.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\\\/\",\"name\":\"Medical Microinstruments Secures $75M to Advance Robotic Microsurgery - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220720005238\\\/en\\\/1518642\\\/21\\\/MMI-GREY-CMYK_CL.jpg\",\"datePublished\":\"2022-07-20T12:01:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220720005238\\\/en\\\/1518642\\\/21\\\/MMI-GREY-CMYK_CL.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220720005238\\\/en\\\/1518642\\\/21\\\/MMI-GREY-CMYK_CL.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medical Microinstruments Secures $75M to Advance Robotic Microsurgery\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medical Microinstruments Secures $75M to Advance Robotic Microsurgery - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\/","og_locale":"en_US","og_type":"article","og_title":"Medical Microinstruments Secures $75M to Advance Robotic Microsurgery - Pharma Trend","og_description":"Series B financing will accelerate clinical trials and global commercialization of the company\u2019s Symani\u00ae Surgical System PISA, Italy–(BUSINESS WIRE)–Medical Microinstruments, Inc. (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced it has raised $75 million in Series B financing. Deerfield Management led the round with participation from new investors, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-20T12:01:42+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220720005238\/en\/1518642\/21\/MMI-GREY-CMYK_CL.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Medical Microinstruments Secures $75M to Advance Robotic Microsurgery","datePublished":"2022-07-20T12:01:42+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\/"},"wordCount":751,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220720005238\/en\/1518642\/21\/MMI-GREY-CMYK_CL.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\/","url":"https:\/\/pharma-trend.com\/en\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\/","name":"Medical Microinstruments Secures $75M to Advance Robotic Microsurgery - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220720005238\/en\/1518642\/21\/MMI-GREY-CMYK_CL.jpg","datePublished":"2022-07-20T12:01:42+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220720005238\/en\/1518642\/21\/MMI-GREY-CMYK_CL.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220720005238\/en\/1518642\/21\/MMI-GREY-CMYK_CL.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/medical-microinstruments-secures-75m-to-advance-robotic-microsurgery\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Medical Microinstruments Secures $75M to Advance Robotic Microsurgery"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46369","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46369"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46369\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46369"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46369"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}